Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Diabetes drug tested as nasal spray for spinal cord injury recovery

NCT ID NCT07384052

Summary

This early-stage study is checking if insulin, delivered as a nasal spray, is safe for people with spinal cord injuries. Researchers will enroll 12 participants who will use either the insulin spray or a placebo spray daily for up to 24 days at home. The main goal is to see if this approach is safe and practical, as a first step toward possibly developing it as a future treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • HealthPartners Neuroscience Center

    RECRUITING

    Saint Paul, Minnesota, 55130, United States

    Contact Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.